淋巴结殖民诱导瘤免疫耐受性促进远程转移
Nathan E Reticker-Flynn1, Weiruo Zhang2, Julia A Belk1
1Department of Pathology, Stanford University, Stanford, CA 94305, USA.
Cell
|May 7, 2022
概括
在固体瘤中,淋巴结转移积极促进远程扩散. 淋巴结中的瘤逃避免疫反应并诱导耐受性,促进进一步的殖民和全身性疾病的进展.
科学领域:
- 癌症学
- 免疫学
- 癌症转移
背景情况:
- 淋巴结的参与是固体恶性瘤的关键预后因素,表明远程转移的潜力.
- 在形成远程转移方面,LN转移的作用尚不清楚.
研究的目的:
- 调查瘤扩散到LN的机制.
- 确定LN殖民是否影响到远处组织的转移.
主要方法:
- 开发LN转移的突发性黑色素瘤小鼠模型.
- 对瘤内在干扰素反应方案的分析.
- 在LN中评估免疫逃避和殖民动态.
主要成果:
- 由表观遗传调节的瘤内在干扰素反应增强了LN转移潜力.
- 这种反应促进了自然杀手 (NK) 细胞的逃避,并促进了LN殖民.
- LN转移抵抗T细胞间接杀死,诱导调节性T细胞,并建立免疫耐受性,促进远程殖民.
结论:
- 通过免疫规避和耐受性诱导,LN转移积极促进远程传播.
- 这种机制在不同类型和种类的癌症中保持一致.
- 了解这一过程为治疗转移性疾病提供了潜在的治疗目标.
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
682
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
682
Cells of the Adaptive Immune Response
4.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.9K


